<SEC-DOCUMENT>0001157523-23-000007.txt : 20230103
<SEC-HEADER>0001157523-23-000007.hdr.sgml : 20230103
<ACCEPTANCE-DATETIME>20230103163031
ACCESSION NUMBER:		0001157523-23-000007
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20230103
FILED AS OF DATE:		20230103
DATE AS OF CHANGE:		20230103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICON PLC
		CENTRAL INDEX KEY:			0001060955
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				981067160

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-08704
		FILM NUMBER:		23502530

	BUSINESS ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		00 353 1 291 2000

	MAIL ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ICON PLC  /ADR/
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a53157641.htm
<DESCRIPTION>ICON PLC 6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using EDGARfilings PROfile 8.4.0.0
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">FORM 6-K</div>
    <div style="text-align: center;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div><br>
    </div>
    <div style="text-align: center;">Washington, D.C. 20549</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">Report of Foreign Private Issuer</div>
    <div style="text-align: center; font-weight: bold;">Pursuant to Rule 13a-16 under</div>
    <div style="text-align: center;">t<font style="font-weight: bold;">he Securities Exchange Act of 1934</font></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center;">For the month of January, 2023</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">ICON plc</div>
    <div style="text-align: center;">(Translation of registrant's name into English)</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">333-08704</div>
    <div style="text-align: center;">&#160;(Commission file number)</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center;">South County Business Park, Leopardstown, Dublin 18, Ireland</div>
    <div style="text-align: center;">(Address of principal executive offices)</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z459b48ccdeb34ea8852b91bca164c269" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 100%; vertical-align: top;" colspan="3">
            <div>Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div>&#160;</div>
          </td>
          <td style="width: 17%; vertical-align: top;">
            <div>Form 20-F __<font style="font-weight: bold;">X</font>___</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>Form 40-F ______</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;" colspan="3">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;" colspan="3">
            <div>Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div>&#160;</div>
          </td>
          <td style="width: 17%; vertical-align: top;">
            <div>Yes______</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>No___<font style="font-weight: bold;">X</font>___</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;" colspan="3">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;" colspan="3">
            <div>Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div>&#160;</div>
          </td>
          <td style="width: 17%; vertical-align: top;">
            <div>Yes______</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>No___<font style="font-weight: bold;">X</font>___</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;"><u>EXHIBIT LIST</u></div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z65225d216f024ec7a1bb55c8a90a1a67" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 14%; vertical-align: top;">
            <div><u>Exhibit</u></div>
          </td>
          <td style="width: 86%; vertical-align: top;">
            <div><u>Description</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 14%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 86%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 14%; vertical-align: top;">
            <div><a href="a53157641ex99_1.htm">99.1</a></div>
          </td>
          <td style="width: 86%; vertical-align: top;">
            <div><a href="a53157641ex99_1.htm">ICON plc to Present at the 41st Annual
                J.P. Morgan Healthcare Conference</a></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">SIGNATURES</div>
    <div><br>
    </div>
    <div>Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
      thereunto duly authorized.</div>
    <div>&#160;</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z67560cd51d9747819d79bf1bef8cc794" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 34%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div style="font-weight: bold;">ICON plc</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 34%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 34%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 34%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 34%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle; border-bottom: #000000 2px solid;">
            <div>/s/ Brendan Brennan</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: top;">
            <div>Date: January 3, 2023</div>
          </td>
          <td style="width: 34%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>Brendan Brennan</div>
            <div>Chief Financial Officer</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a53157641ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using EDGARfilings PROfile 8.4.0.0
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
  </div>
  <div style="text-align: right;"><font style="font-weight: bold;"> <br>
    </font></div>
  <div><font style="font-weight: bold;"> </font>
    <div class="bw-release">
      <div class="bw-release">
        <div class="bw-release">
          <h1 style="text-align: center; list-style-position: inside;FONT-SIZE: 14pt;"> <b>ICON plc to Present at the 41<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> Annual J.P. Morgan Healthcare Conference</b> </h1>
          <div class="bw-release-body">
            <div class="bw-release-table-js bw-release-story">
              <p>DUBLIN, Ireland--(BUSINESS WIRE)--January 3, 2023--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 41<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup>
                Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 5:15pm PST/ 8.15pm EST. </p>
              <p> Any changes to these events and links to the live webcasts (where available) will be posted on the Investor section of our website under &#8220;Events&#8221;. </p>
              <p> <b>About ICON plc</b> </p>
              <p> ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government
                and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,150 employees in 113 locations in 53 countries as
                at September 30, 2022. For further information about ICON, visit: www.iconplc.com. </p>
              <p> This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not
                guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks,
                uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the
                opening of new offices and offering of new services, the integration of new business mergers and acquisitions, the impact of COVID-19 on our business, as well as other economic and global market conditions and other risks and uncertainties
                detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making
                investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any
                obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in
                SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov. </p>
              <p> Source: ICON plc </p>
              <p> <b>ICON/ICLR-G</b> </p>
            </div>
            <div class="bw-release-contact">
              <h2 style="FONT-SIZE: 14pt;">Contacts</h2>
              <p> Kate Haven Vice President Investor Relations +1888 381 7923 </p>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
